Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase EARLY_PHASE1 2Phase 1 2Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 5Lymphoid 3Gastrointestinal 3Plasma cell 2NET 2Endocrine 2Breast 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Lymphoma 2Hodgkin Disease 2Lymphoma, T-Cell 1Lymphoma, B-Cell 1

Interventions

Rituximab 689Cyclophosphamide 615Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 228Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 176Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106obinutuzumab 105Tacrolimus 105Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Positron Emission Tomography Computed Tomography × Lymphoid × Clear all
NCT03615664 2025-01-16

BURGUND

Polish Lymphoma Research Group

Phase 2 Completed
115 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT04121507 2023-05-24

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

GWT-TUD GmbH

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, B-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡